Latest Headlines
-
bioMérieux Strengthens Its Next-Generation Sequencing Capabilities With The Acquisition Of Day Zero Diagnostics Solutions And Technologies
6/16/2025
bioMérieux, a world leader in the field of in vitro diagnostics, announces an agreement to acquire the assets of Day Zero Diagnostics, a US-based infectious disease diagnostics company using genome sequencing and machine learning to combat the rise of antibiotic-resistant infections.
-
Abbott Receives Health Canada Authorization For Whole Blood Rapid Test To Help Assess Suspected Concussions
6/16/2025
Abbott (NYSE: ABT) announced today that Health Canada has approved the company's i-STAT TBI test cartridge for use with whole blood, helping clinicians to assess suspected concussion at the patient's bedside and obtain lab-quality results in 15 minutes.
-
Gilson Launches PIPETMAN M96: Simplifying High-Throughput Pipetting With Speed, Precision, And Confidence
6/16/2025
Gilson is proud to announce the launch of PIPETMAN M96 , a 96-channel motorized pipette designed to bring efficient, semi-automated pipetting to any lab bench.
-
Solutions For Safe, Efficient, And High-Purity Automation Applications
6/12/2025
At this year’s Automatica trade fair, the Fraunhofer Institute for Manufacturing Engineering and Automation IPA will be showcasing numerous solutions that – thanks in part to artificial intelligence (AI) – greatly simplify and accelerate the planning, programming, and training of robots.
-
Volta Labs Expands Long-Read Sequencing Capabilities With Automated Oxford Nanopore Library Prep App On Callisto™
6/12/2025
Volta Labs, a genomics applications company, today announced the launch of its Library Prep App for Oxford Nanopore LSK114 on the Callisto™ Sample Prep System. This latest addition to the growing Volta apps menu extends Callisto's footprint in long-read sequencing.
-
Seek Labs Unveils BioSeeker
6/10/2025
Seek Labs—a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics—today announced BioSeeker, a next-generation AI discovery engine redefining how the world identifies and treats disease.
-
Salimetrics CoreLab+ Expands Access To Dried Blood Spot Testing For Researchers
6/10/2025
Today, Salimetrics continues its mission to provide tools that support biobehavioral investigators across disciplines, from developmental science to behavioral health, to general health and wellness, and beyond.
-
FUJIFILM Healthcare Europe And IBEX Announce Partnership To Streamline Workflows And Enhance Diagnostic Capabilities In Digital Pathology
6/10/2025
FUJIFILM Healthcare Europe, the global leader in Digital Pathology software1 and Ibex Medical Analytics (Ibex), a leader in AI-powered cancer diagnostics in Pathology, are delighted to announce a formal partnership to support efficient and accurate cancer diagnosis.
-
Access Medical Labs, A Subsidiary Of Empresas Aries, Completes Historic Lab Expansion With Roche Diagnostics Systems
6/10/2025
In a milestone rarely achieved in the clinical laboratory industry, Access Medical Labs — the largest private diagnostic lab in Florida — has completed a full transition from Siemens to Roche Diagnostics systems in under 6 months.
-
Svar Life Science And Lablytica Life Science Announce Strategic Partnership To Expand Bioanalytical Services With Advanced LCMS/MS Capabilities
6/10/2025
Svar Life Science, a leading provider of bioanalytical and diagnostic solutions, is proud to announce a strategic partnership with Lablytica Life Science, a Swedish contract research organization (CRO) specializing in advanced bioanalytical services.